Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

J.C. Penney Company, Inc. (JCP): A Hedge Fund Boosts Its Stake

Page 1 of 2

A market-moving update, Larry Robbins’ hedge fund Glenview Capital Management just disclosed ownership of about 20.1 million shares of J.C. Penney Company, Inc. (NYSE:JCP), in a 13G filing with the Security and Exchange Commission. The value of the stake amounts to $273.4 million, at the current price of the company’s stock. In comparison with the stake disclosed in the fund’s second quarter 13F filing, Robbins’ hedge fund increased the position in J.C. Penney Company, Inc. (NYSE:JCP) by over 11.6 million shares.

If we take a look at the Glenview’s equity portfolio from the last year, we can notice that Larry Robbins has been bullish on J.C. Penney. The hedge fund first purchased a stake in J.C. Penney Company in the third quarter of 2012, the position at that time containing about 4.5 million shares, valued at $108.3 million. During the quarters following the purchase, Glenview has been strengthening its position in the company, and only during the second quarter of 2013, the hedge fund dumped about 1.1 million shares.


At present, there are a lot of analytical tools for J.C. Penney Company, Inc. (NYSE:JCP) investors to watch, but it’s extremely useful to be aware of a company’s hedge funds. One path we can use is: (a) the total number of hedge funds that are optimistic about a particular company, in addition to (b) which specific funds are stockholders.

An increased amount of smart money interest typically means what you’d think: the top minds on Wall Street have turned more optimistic about the stock.

Here at Insider Monkey, it is not a secret that we watch hedge funds’ interest, but it is extremely crucial to parse this information into the highest-tier of fund managers. For those searching for a market-beating piggybacking strategy, discover the details of our premium strategy.

With that in mind, let’s take a glance at the recent info swirling around J.C. Penney Company, Inc. (NYSE:JCP).

Studying the latest 13F hedge fund data, which is released once a quarter, we can realize that J.C. Penney Company, Inc. (NYSE:JCP) has a select group of funds invested.

After analyzing the latest batch of 13Fs, Pershing Square, managed by Bill Ackman, holds the largest position in J.C. Penney Company, Inc. (NYSE:JCP). Pershing Square has a $287.8 million position in the stock, comprising 6.1% of its 13F portfolio. Coming in second is Soros Fund Management, headed by George Soros, which held a $287.1 million position; the fund has 3.7% of its 13F portfolio invested in the stock. Two more hedgies that are also bullish include Richard Perry’s Perry Capital, and Patrick McCormack’s Tiger Consumer Management.

Also, insider buying is at its handiest when the primary stock in question has seen transactions within the past 180 days. Over the latest 180-day time period, J.C. Penney Company, Inc. (NYSE:JCP) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to J.C. Penney Company, Inc. (NYSE:JCP). These stocks are Sears Hometown and Outlet Stores Inc (NASDAQ:SHOS), Kohl’s Corporation (NYSE:KSS), Saks Inc (NYSE:SKS), Sears Holdings Corporation (NASDAQ:SHLD), and Dillard’s, Inc. (NYSE:DDS). This group of stocks are the members of the department stores industry and their market caps resemble JCP’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!